Form 4: J.H. Whitney Equity Partners VII, LLC Sells Shares of Aveanna Healthcare Holdings, Inc. (AVAH) Under 10b5-1 Plan

J.H. Whitney Equity Partners VII, LLC, along with affiliated entities, sold shares of Aveanna Healthcare Holdings, Inc. (AVAH) under a pre-arranged Rule 10b5-1 trading plan.

Summary

• J.H. Whitney Equity Partners VII, LLC, and related entities including J.H. Whitney VII, L.P., PSA Healthcare Investment Holding LLC, and PSA Iliad Holdings LLC, filed a Form 4 detailing changes in beneficial ownership of Aveanna Healthcare Holdings, Inc. (AVAH).
• The transactions involved the sale of common stock under a Rule 10b5-1 trading plan adopted on December 13, 2024.
• On March 18, 2025, 39,825 shares were sold at a weighted average price of $5.51, with prices ranging from $5.43 to $5.62.
• On March 19, 2025, 46,912 shares were sold at a weighted average price of $5.46, with prices ranging from $5.40 to $5.56.
• After these transactions, J.H. Whitney VII, L.P. beneficially owns 31,388,159 shares, PSA Healthcare Investment Holding LLC owns 15,681,861 shares, and PSA Iliad Holdings LLC owns 1,451,778 shares.
• J.H. Whitney Equity Partners VII, LLC is the general partner of J.H. Whitney VII, L.P. and Whitney Strategic Partners VII, L.P., which is the managing member of PSA Healthcare and PSA Iliad Holdings.

Sentiment

Score: 5

Explanation: Neutral sentiment as the document simply reports transactions under a pre-existing trading plan. There is no indication of positive or negative outlook.

Risks

• Continued sales under the 10b5-1 plan could exert downward pressure on AVAH's stock price.

Future Outlook

The document indicates ongoing sales under a pre-arranged 10b5-1 trading plan, suggesting continued transactions in the near term.

Industry Context

The healthcare sector is often subject to scrutiny regarding insider trading and large shareholder transactions. This filing provides transparency into the trading activities of a major shareholder in Aveanna Healthcare Holdings, Inc.

Comparison to Industry Standards

• Rule 10b5-1 trading plans are a common mechanism for corporate insiders and major shareholders to sell shares without being accused of trading on non-public information.
• The disclosure of these transactions via Form 4 filings is standard practice and ensures transparency in the market.
• Comparable companies in the healthcare sector often have similar filings related to insider transactions.

Stakeholder Impact

• Shareholders may react to the news of continued share sales by a major shareholder.
• The impact on employees, customers, suppliers, and creditors is likely to be minimal unless the sales significantly impact the company's financial stability.

Key Dates

Keywords

Aveanna Healthcare Holdings, AVAH, J.H. Whitney Equity Partners VII, J.H. Whitney VII, PSA Healthcare Investment Holding, PSA Iliad Holdings, Form 4, 10b5-1 trading plan, share sale, beneficial ownership